Withania somnifera
Species
KNApSAcK Entry
| Organism name | Withania somnifera |
|---|---|
| Genus | Withania |
| Family | Solanaceae |
| Kingdom | Plantae |
NCBI taxonomy
Entry
| Linked NCBI taxonomy name | Withania somnifera |
|---|---|
| Linked NCBI taxonomy ID | 126910 |
| Linked level | species |
Family
| Family in NCBI taxonomy | Solanaceae |
|---|---|
| ID | 4070 |
Kingdom (Superkingdom)
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
Plant class
| Plant class | asterids |
|---|---|
| ID | 71274 |
Natural Activity
List (64)
| Species | Activity |
|---|---|
| Withania somnifera (L.) Dunal | Abortifacient |
| Withania somnifera (L.) Dunal | Adaptogen |
| Withania somnifera (L.) Dunal | Alterative |
| Withania somnifera (L.) Dunal | Amebicide |
| Withania somnifera (L.) Dunal | Anabolic |
| Withania somnifera (L.) Dunal | Analgesic |
| Withania somnifera (L.) Dunal | Antiaging |
| Withania somnifera (L.) Dunal | Antianemic |
| Withania somnifera (L.) Dunal | Antiarthritic |
| Withania somnifera (L.) Dunal | Antibacterial |
| Withania somnifera (L.) Dunal | Antiedemic |
| Withania somnifera (L.) Dunal | Antiendotoxin |
| Withania somnifera (L.) Dunal | Antiepileptic |
| Withania somnifera (L.) Dunal | Antifertility |
| Withania somnifera (L.) Dunal | Antiherpetic |
| Withania somnifera (L.) Dunal | Antiinflammatory |
| Withania somnifera (L.) Dunal | Antimitotic |
| Withania somnifera (L.) Dunal | Antioxidant |
| Withania somnifera (L.) Dunal | Antiproliferative |
| Withania somnifera (L.) Dunal | Antipyretic |
| Withania somnifera (L.) Dunal | Antisarcomic |
| Withania somnifera (L.) Dunal | Antiseptic |
| Withania somnifera (L.) Dunal | Antispasmodic |
| Withania somnifera (L.) Dunal | Antistress |
| Withania somnifera (L.) Dunal | Antitumor |
| Withania somnifera (L.) Dunal | Antiulcer |
| Withania somnifera (L.) Dunal | Antiviral |
| Withania somnifera (L.) Dunal | Aphrodisiac |
| Withania somnifera (L.) Dunal | Bradycardic |
| Withania somnifera (L.) Dunal | Cerebrotonic |
| Withania somnifera (L.) Dunal | Chemopreventive |
| Withania somnifera (L.) Dunal | CNS-Depressant |
| Withania somnifera (L.) Dunal | Contraceptive |
| Withania somnifera (L.) Dunal | Cytotoxic |
| Withania somnifera (L.) Dunal | Deobstruent |
| Withania somnifera (L.) Dunal | Diuretic |
| Withania somnifera (L.) Dunal | Ecbolic |
| Withania somnifera (L.) Dunal | Emmenagogue |
| Withania somnifera (L.) Dunal | Fungicide |
| Withania somnifera (L.) Dunal | GABA-nergic |
| Withania somnifera (L.) Dunal | Hemopoietic |
| Withania somnifera (L.) Dunal | Hepatoprotective |
| Withania somnifera (L.) Dunal | Hypnotic |
| Withania somnifera (L.) Dunal | Hypotensive |
| Withania somnifera (L.) Dunal | Immunodepressant |
| Withania somnifera (L.) Dunal | Immunomodulator |
| Withania somnifera (L.) Dunal | Immunostimulant |
| Withania somnifera (L.) Dunal | Insecticide |
| Withania somnifera (L.) Dunal | Interferonogenic |
| Withania somnifera (L.) Dunal | Lactagogue |
| Withania somnifera (L.) Dunal | Memorigenic |
| Withania somnifera (L.) Dunal | Narcotic |
| Withania somnifera (L.) Dunal | Nervine |
| Withania somnifera (L.) Dunal | Pain |
| Withania somnifera (L.) Dunal | Pediculicide |
| Withania somnifera (L.) Dunal | Phagocytotic |
| Withania somnifera (L.) Dunal | Poison |
| Withania somnifera (L.) Dunal | Proteolytic |
| Withania somnifera (L.) Dunal | Respirastimulant |
| Withania somnifera (L.) Dunal | Sedative |
| Withania somnifera (L.) Dunal | Staminagenic |
| Withania somnifera (L.) Dunal | Tonic |
| Withania somnifera (L.) Dunal | Tranquilizer |
| Withania somnifera (L.) Dunal | Vermifuge |
Metabolite list (43)
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
C00005629
|
6,8-Dihydroxykaempferol 3-rutinoside
|
No. 1 | No. 15 |
|
||||
|
C00005472
|
Quercetin 3-rutinoside-7-glucoside
|
No. 5 | No. 15 |
|
||||
|
C00003672
|
Sitosterol
/ beta-sitosterl / (-)-beta-Sitosterol / Stigmast-5-en-3beta-ol |
CHEMBL221542
CHEMBL1398443 CHEMBL1875388 |
17 / 19 / 12 | No. 53 | No. 11 |
|
||
|
C00003674
|
Stigmasterol
/ beta-Stigmasterol |
CHEMBL66943
CHEMBL186373 CHEMBL400247 CHEMBL1568947 |
D013265
|
5 / 0 / 0 | 1 / 0 | No. 53 | No. 11 |
|
|
C00033134
|
Lycium substance B
|
No. 176 | No. 58 |
|
||||
|
C00035165
|
Withastramonolide
|
No. 176 | No. 58 |
|
||||
|
C00034339
|
Withanone
|
CHEMBL516703
|
No. 176 | No. 58 |
|
|||
|
C00035011
|
27-Hydroxywithanone
|
No. 176 | No. 58 |
|
||||
|
C00003676
|
Withaferin A
|
CHEMBL517080
CHEMBL578716 CHEMBL1221986 CHEMBL1419012 CHEMBL2143369 |
C009684
|
27 / 22 / 15 | 7 / 2 | No. 176 | No. 58 |
|
|
C00003677
|
Withaferin D
/ Withanolide D |
CHEMBL1222037
|
C010376
|
2 / 0 / 0 | No. 176 | No. 58 |
|
|
|
C00035210
|
17-Hydroxy withaferin A
|
CHEMBL2047414
|
No. 176 | No. 58 |
|
|||
|
C00031534
|
Dihydrowithaferin A
/ 2,3-Dihydrowithaferin A |
CHEMBL1934585
|
No. 176 | No. 58 |
|
|||
|
C00019308
|
Doursterol
/ Daucosterin / 3-O-beta-D-Glucopyranosyl sitosterol / beta-Sitosterol 3-O-beta-D-glucopyranoside |
CHEMBL197711
CHEMBL506678 CHEMBL2304043 |
C011015
|
5 / 4 / 2 | 0 / 3 | No. 520 |
|
|
|
C00029509
|
Stigmasterol-3-O-beta-D-glucopyranoside
/ beta-Stigmasteryl 3-O-beta-D-glucopyranoside |
CHEMBL447335
|
C054293
|
2 / 0 / 0 | No. 520 |
|
||
|
C00002283
|
Calystegin B2
/ Calystegine B2 |
CHEMBL526330
CHEMBL513797 CHEMBL1213469 CHEMBL1984376 |
C095613
|
1 / 6 / 4 | No. 643 | No. 1 |
|
|
|
C00036868
|
Calystegine C1
/ (+)-Calystegine C1 |
CHEMBL1972699
|
No. 643 | No. 1 |
|
|||
|
C00033489
|
Withacoagin
/ (+)-Withacoagin |
No. 729 |
|
|||||
|
C00033490
|
Withanoside II
/ (-)-Withanoside II |
No. 742 |
|
|||||
|
C00033492
|
Withanoside IV
/ (+)-Withanoside IV |
No. 742 |
|
|||||
|
C00033493
|
Withanoside IX
|
No. 742 |
|
|||||
|
C00033494
|
Withanoside V
|
CHEMBL1707418
|
1 / 0 / 0 | No. 742 |
|
|||
|
C00033495
|
Withanoside VI
/ (-)-Withanoside VI |
No. 742 |
|
|||||
|
C00033496
|
Withanoside VIII
|
No. 742 |
|
|||||
|
C00033497
|
Withanoside X
/ (+)-Withanoside X |
No. 742 |
|
|||||
|
C00026611
|
Withanamide H
|
No. 1096 |
|
|||||
|
C00026612
|
Withanamide I
|
No. 1096 |
|
|||||
|
C00026604
|
Withanamide A
|
No. 1096 |
|
|||||
|
C00026610
|
Withanamide G
|
No. 1096 |
|
|||||
|
C00026609
|
Withanamide F
|
No. 1096 |
|
|||||
|
C00026606
|
Withanamide C
|
No. 1096 |
|
|||||
|
C00026608
|
Withanamide E
|
No. 1096 |
|
|||||
|
C00026607
|
Withanamide D
|
No. 1096 |
|
|||||
|
C00026605
|
Withanamide B
|
No. 1096 |
|
|||||
|
C00033491
|
Withanoside III
/ (-)-Withanoside III |
No. 1828 |
|
|||||
|
C00031019
|
Physagulin D
|
No. 1828 |
|
|||||
|
C00033498
|
Withanoside XI
/ (+)-Withanoside XI |
No. 1828 |
|
|||||
|
C00032847
|
Coagulin Q
/ (+)-Coagulin Q |
No. 1828 |
|
|||||
|
C00002034
|
Cuscohygrine
/ meso-Cuscohygrine |
C098327
|
No. 2565 | No. 1 |
|
|||
|
C00002301
|
Pseudotropine
|
CHEMBL113555
CHEMBL1356617 CHEMBL2165231 |
6 / 13 / 13 | No. 2640 | No. 1 |
|
||
|
C00002306
|
Tropine
|
CHEMBL113555
CHEMBL1356617 CHEMBL2165231 |
C005864
|
6 / 13 / 13 | No. 2640 | No. 1 |
|
|
|
C00002369
|
Withasomnine
|
No. 7830 |
|
|||||
|
C00041360
|
Ashwagandhanolide
/ (+)-Ashwagandhanolide |
CHEMBL507211
|
2 / 0 / 3 | No. 8286 |
|
|||
|
C00002016
|
(-)-Anaferine
|
No. 8771 | No. 1 |
|
Human Protein / Gene in interactions
52 ChEMBL Protein in interactions
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P06746 | DNA polymerase beta | Enzyme | C00003672 C00003674 C00003676 C00019308 | 0 / 0 |
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002301 C00002306 C00003672 | 1 / 1 |
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002301 C00002306 C00003672 | 0 / 1 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002301 C00002306 C00003672 | 0 / 1 |
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002301 C00002306 C00003672 | 1 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002301 C00002306 C00003672 | 0 / 0 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003672 C00003676 | 2 / 0 |
| P11142 | Heat shock cognate 71 kDa protein | Unclassified protein | C00003676 C00003677 | 0 / 0 |
| P02545 | Prelamin-A/C | Unclassified protein | C00002301 C00002306 | 11 / 10 |
| P08047 | Transcription factor Sp1 | Unclassified protein | C00003672 C00019308 | 0 / 0 |
| P00734 | Prothrombin | S1A | C00003672 C00019308 | 4 / 2 |
| P07355 | Annexin A2 | Unclassified protein | C00003676 C00003677 | 0 / 0 |
| P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003672 C00019308 | 0 / 0 |
| O75496 | Geminin | Unclassified protein | C00003676 C00033494 | 0 / 0 |
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003672 C00019308 | 0 / 0 |
| Q9Y253 | DNA polymerase eta | Enzyme | C00003676 | 1 / 1 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00003676 | 0 / 0 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00003676 | 0 / 0 |
| P11473 | Vitamin D3 receptor | NR1I1 | C00003676 | 2 / 3 |
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00041360 | 0 / 0 |
| P42858 | Huntingtin | Unclassified protein | C00003676 | 1 / 1 |
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00003676 | 2 / 0 |
| P51452 | Dual specificity protein phosphatase 3 | Ser_Thr_Tyr | C00029509 | 0 / 0 |
| P51151 | Ras-related protein Rab-9A | Unclassified protein | C00003676 | 0 / 0 |
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00003676 | 1 / 0 |
| P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00003674 | 0 / 0 |
| P08183 | Multidrug resistance protein 1 | drug | C00003672 | 1 / 0 |
| P42574 | Caspase-3 | C14 | C00003676 | 0 / 0 |
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00003672 | 3 / 2 |
| P14679 | Tyrosinase | Oxidoreductase | C00003672 | 4 / 2 |
| P35236 | Tyrosine-protein phosphatase non-receptor type 7 | Tyr | C00029509 | 0 / 0 |
| P04062 | Glucosylceramidase | Enzyme | C00002283 | 6 / 4 |
| O15118 | Niemann-Pick C1 protein | Unclassified protein | C00003676 | 1 / 1 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00003676 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00003672 | 1 / 1 |
| P09884 | DNA polymerase alpha catalytic subunit | Transferase | C00003674 | 0 / 0 |
| P31749 | RAC-alpha serine/threonine-protein kinase | Akt | C00003676 | 4 / 1 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00041360 | 0 / 3 |
| Q99700 | Ataxin-2 | Unclassified protein | C00003676 | 1 / 1 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00003676 | 0 / 0 |
| Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00003676 | 1 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00003676 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00003676 | 4 / 3 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00003676 | 0 / 0 |
| P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00003672 | 1 / 1 |
| P17861 | X-box-binding protein 1 | Unclassified protein | C00003676 | 1 / 0 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00003672 | 1 / 1 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00003676 | 1 / 0 |
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00003674 | 0 / 0 |
| Q02880 | DNA topoisomerase 2-beta | Isomerase | C00003674 | 0 / 0 |
| P01215 | Glycoprotein hormones alpha chain | Unclassified protein | C00003676 | 0 / 3 |
| Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00003676 | 2 / 1 |
8 Gene in CTD interactions
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 468 | ATF4, CREB-2, CREB2, TAXREB67, TXREB | activating transcription factor 4 |
C00003676
|
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00003676
|
| 1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 |
C00003676
|
| 54541 | DDIT4, Dig2, REDD-1, REDD1 | DNA-damage-inducible transcript 4 |
C00003676
|
| 83939 | EIF2A, EIF-2A, MST089, MSTP004, MSTP089 | eukaryotic translation initiation factor 2A, 65kDa |
C00003676
|
| 5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00003676
|
| 7494 | XBP1, TREB5, XBP-1, XBP2 | X-box binding protein 1 |
C00003676
|
| 10599 | SLCO1B1, HBLRR, LST-1, LST1, OATP-C, OATP1B1, OATP2, OATPC, SLC21A6 | solute carrier organic anion transporter family, member 1B1 |
C00003674
|
Related Diseases
Diseases related to proteins in ChEMBL interactions
OMIM (56)
| OMIM | preferred title | UniProt |
|---|---|---|
| #103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
| #203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
| #606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
| #218030 | Apparent mineralocorticoid excess; ame |
P80365
|
| #608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
| #114480 | Breast cancer |
P31749
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #114500 | Colorectal cancer; crc |
P31749
P84022 Q14191 |
| #615109 | Cowden syndrome 6; cws6 |
P31749
|
| #609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
| #608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #143100 | Huntington disease; hd |
P42858
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
| #612371 | Major affective disorder 7; mafd7 |
P17861
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
| #601665 | Obesity |
P32245
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #172700 | Pick disease of brain |
P10636
|
| #614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
| #176920 | Proteus syndrome |
P31749
|
| #613679 | Prothrombin deficiency, congenital |
P00734
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #601367 | Stroke, ischemic |
P00734
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| #277700 | Werner syndrome; wrn |
Q14191
|
| #278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG DISEASE (42)
| KEGG | name | UniProt |
|---|---|---|
| H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
| H00223 | Inherited thrombophilia |
P00734
(related)
|
| H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
| H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
| H00082 | Graves' disease |
P01215
(marker)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
P16473 (related) |
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
|
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H01205 | Coumarin resistance |
P11712
(related)
|
| H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
| H00038 | Malignant melanoma |
P14679
(marker)
|
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
| H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
| H00017 | Esophageal cancer |
P35354
(related)
|
| H00025 | Penile cancer |
P35354
(related)
|
| H00046 | Cholangiocarcinoma |
P35354
(related)
|
| H00059 | Huntington's disease (HD) |
P42858
(related)
|
| H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
| H00296 | Defects in RecQ helicases |
Q14191
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
| H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|